Barry J. Cusack - Concepedia

Author

Barry J. Cusack

University of Washington

Also Known As

B J Cusack, B. J. Cusack, B.J. Cusack, Barry J Cusack, Barry J. Cusack, Stephen C. Montamat

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Washington Boise VA Medical Center Brigham and Women's Hospital Boise State University Harvard University

About

Barry J. Cusack is an author at University of Washington specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	26	1.2K
2	Biochemistry	6	6	185
3	Health Sciences	2	2	155
4	Natural Sciences	1	1	16
5	Public Health	1	1	31

Barry J. Cusack

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Richard D. Olson, Phillip S. Mushlin, Dean E. Brenner, Proceedings of the National Academy of Sciences Doxorubicin CardiotoxicityHeart FailurePathologyPharmacotherapyCardiovascular Toxicity	1988	352
Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model. Debra A. Dodd, James B. Atkinson, Richard D. Olson, Journal of Clinical Investigation Cardiac MuscleHeart FailureCardiovascular PharmacologyPathologyCalcium Release Channel	1993	117
Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men. Joseph J. Crowley, Barry J. Cusack, Sandra G. Jue, Journal of Pharmacology and Experimental Therapeutics	1988	103
Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine Briant E. Burke, Richard D. Olson, Barry J. Cusack Biomedicine & Pharmacotherapy Menstrual MigraineHormonal ContraceptiveCluster HeadacheMedicineProphylactic Treatment	2002	79
Time‐related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function Phillip S. Mushlin, Barry J. Cusack, Robert J. Boucek, British Journal of Pharmacology	1993	71
Daunorubicin cardiotoxicity Susan E. Shadle, Brad P. Bammel, Barry J. Cusack, Biochemical Pharmacology	2000	68
Doxorubicin Cardiac Dysfunction: Effects on Calcium Regulatory Proteins, Sarcoplasmic Reticulum, and Triiodothyronine Richard D. Olson, Hervé A. Gambliel, Robert E. Vestal, Cardiovascular Toxicology Cardiac MuscleCardiomyopathyHeart FailureSarcoplasmic ReticulumCalcium Regulatory Proteins	2005	62
Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit Barry J. Cusack, Stephan P. Young, Joni Driskell, Cancer Chemotherapy and Pharmacology Bolus InjectionMedicineClinical PharmacologyExperimental PharmacologyPharmacotherapy	1993	59
Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pump Hisato Harada, Barry J. Cusack, Richard D. Olson, Biochemical Pharmacology Cardiac MuscleCardiomyopathyHeart FailureMedicinePhysiology	1990	56
Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation Christopher Nielson, Joseph J. Crowley, Barry J. Cusack, Journal of Allergy and Clinical Immunology Inhibit Leukocyte ActivationMedicinal ChemistryMedicineImmunologyNeuropharmacology	1986	49

Page 1